Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-585-2399800
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees28
Next Earnings DateN/A
OptionableNot Optionable
Lucid (OTCMKTS:LCDX) Frequently Asked Questions
What is Lucid's stock symbol?
Lucid trades on the OTCMKTS under the ticker symbol "LCDX."
Has Lucid been receiving favorable news coverage?
Press coverage about LCDX stock has trended somewhat negative this week, InfoTrie reports. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Lucid earned a media sentiment score of -1.1 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near term.
Who are some of Lucid's key competitors?
Some companies that are related to Lucid include Smith & Nephew (SN), Consort Medical (CSRT), Corindus Vascular Robotics (CVRS), Ekf Diagnostics (EKF), Theralase Technologies (TLT), Immunodiagnostic Systems (IDH), LiDCO Group (LID), Intelligent Ultrasound Group (MED), Zecotek Photonics (ZMS), InspireMD (NSPR), Deltex Medical Group (DEMG), Bioquell (BQE) and Verisante Technology (VRS).
What other stocks do shareholders of Lucid own?
Who are Lucid's key executives?
Lucid's management team includes the folowing people:
- Mr. William J. Shea, Exec. Chairman (Age 71)
- Mr. L. Michael Hone, CEO & Director (Age 69)
- Mr. William J. Fox, CTO & VP of Technology Operations (Age 53)
- Ms. Karen Howe, Chief Financial Officer
- Mr. Robert T. Kelley, VP of Sales and Marketing
How do I buy shares of Lucid?
Shares of LCDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Lucid's stock price today?
One share of LCDX stock can currently be purchased for approximately $0.72.
What is Lucid's official website?
How can I contact Lucid?
Lucid's mailing address is 100 Burtt Rd Ste 203, ANDOVER, MA 01810-5920, United States. The company can be reached via phone at +1-585-2399800.
MarketBeat Community Rating for Lucid (OTCMKTS LCDX)
MarketBeat's community ratings are surveys of what our community members think about Lucid and other stocks. Vote "Outperform" if you believe LCDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCDX will underperform the S&P 500 over the long term. You may vote once every thirty days.
